Artemether + Lumefantrine tablet bulk supplier for pharma manufacturers

Artemether + Lumefantrine Tablet 20 mg/120 mg per tablet Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 20 mg/120 mg per tablet

Reference Brands: Coartem(EU)

Artemether–Lumefantrine inhibits Plasmodium falciparum by disrupting parasite DNA and calcium homeostasis, leading to parasite death. It effectively treats uncomplicated malaria, offering rapid symptom relief, high cure rates, and convenient oral dosing. Its combination prevents resistance development, making it a preferred first-line therapy in endemic regions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Artemether + Lumefantrine tablets, marketed as Coartem, are approved in some EU countries for uncomplicated Plasmodium falciparum malaria. In the EU, brands are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards, though approval status varies. In the US, the combination is not approved for malaria treatment, but importation for travel use is permitted. Both regions require detailed dossiers, clinical trial data, quality assurance, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access, ensuring adherence to European and US standards for safe, effective malaria therapy.

Artemether + Lumefantrine Tablet — third party manufacturing & bulk supply

Artemether + Lumefantrine Tablet 20 mg/120 mg per tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Artemether + Lumefantrine Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Artemether + Lumefantrine Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Artemether + Lumefantrine Tablet →

Back to Listing

Frequently Asked Questions

Artemether + Lumefantrine tablet is listed as Tablet in 20 mg/120 mg per tablet. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Artemether + Lumefantrine tablet is referenced against Coartem(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.